The acute oral toxicity test in rats and mice is a core in vivo safety study used to determine the median lethal dose (LD50) and systemic hazard profile of chemicals, food additives, pesticides, cosmetics ingredients, and medical device materials following single-dose oral exposure. Performed by GLP-compliant accredited third-party laboratories under internationally recognized protocols such as OECD Test Guidelines and Chinese national standards (GB), the study delivers essential data for GHS classification, regulatory registration, and risk assessment. This article explains the technical principles, sample types, test items, methodologies, applications, and frequently asked questions related to rat and mouse oral toxicity safety evaluation.
Technical Overview
Acute oral toxicity refers to the adverse effects that occur within a short period of time after either a single oral administration of a test substance or multiple oral administrations given within 24 hours. The rat and mouse acute oral toxicity test is the most widely used first-tier in vivo study in toxicological safety assessment. Its primary objective is to determine the median lethal dose (LD50), the statistically derived single dose expected to cause death in 50% of treated animals, together with the observation of clinical signs, time of onset and duration of toxicity, and reversibility of effects.
In a typical study, healthy adult Sprague-Dawley or Wistar rats and ICR or Kunming mice of a defined weight range are acclimatized for several days, fasted briefly before dosing, and then receive a single oral gavage administration of the test substance. Animals are observed intensively during the first hours after dosing and at least once daily throughout a 14-day observation period, with body weight recorded regularly and gross necropsy performed on all animals at termination.
The study is conducted in accordance with internationally recognized protocols, including OECD Test Guideline 420 (Fixed Dose Procedure), OECD Test Guideline 423 (Acute Toxic Class Method), OECD Test Guideline 425 (Up-and-Down Procedure), GB 15193.3 (National Food Safety Standard for acute oral toxicity testing of food-related substances), GB/T 21605 (acute oral toxicity of chemicals), and ISO 10993-11 for systemic toxicity evaluation of medical devices. All work is performed in GLP-compliant facilities under animal ethics approval, applying the 3Rs principles of Replacement, Reduction, and Refinement to minimize animal use and suffering.
Testing Samples
Accredited third-party laboratories accept a broad spectrum of test substances for acute oral toxicity safety assessment, covering nearly every industry sector in which products may be ingested, mouthed, or accidentally swallowed.
Industrial Chemicals and New Chemical Substances
Raw materials, intermediates, monomers, catalysts, surfactants, dyes, solvents, and nanomaterials are tested to support new chemical substance notification, hazard classification, and safety data sheet development. Both neat substances and formulated mixtures can be evaluated.
Food, Food Additives, and Food-Related Products
New food ingredients, food additives, processing aids, novel foods, enzyme preparations, and food contact materials are assessed under the GB 15193 toxicological testing framework to support food safety evaluation and market approval in China and other jurisdictions.
Pesticides and Agrochemicals
Technical-grade active ingredients, technical concentrates, and end-use formulations undergo acute oral toxicity testing as a mandatory component of pesticide registration dossiers and product labeling requirements.
Cosmetics Ingredients and Personal Care Products
Ingredients with the potential for incidental ingestion, as well as raw materials requiring hazard identification for occupational handling and classification, are evaluated to support cosmetic ingredient safety dossiers and supply-chain compliance.
Medical Devices and Biomaterials
Devices with oral or mucosal contact, ingestible components, or leachable materials are extracted using polar and non-polar solvents per ISO 10993-12, and the resulting extracts are evaluated for acute systemic toxicity in accordance with ISO 10993-11 and the corresponding GB/T 16886 series.
Household, Consumer, and Veterinary Products
Cleaning agents, disinfectants, laundry products, air care products, toys and children's articles that may be mouthed, and veterinary preparations are tested to characterize accidental ingestion hazards and support consumer safety documentation.
Testing Items
The rat and mouse oral toxicity safety assessment typically encompasses the following test items and endpoints, tailored to the regulatory purpose and the expected toxicity of the sample.
- Acute oral LD50 determination with 95% confidence limits, where applicable
- Limit test at 2000 mg/kg body weight (or 5000 mg/kg with regulatory justification) for substances expected to be of low toxicity
- Acute Toxic Class study per OECD TG 423, assigning a defined LD50 range and GHS category
- Fixed Dose Procedure per OECD TG 420, using evident toxicity rather than lethality as the primary endpoint
- Up-and-Down Procedure per OECD TG 425, providing a point LD50 estimate with minimal animal use
- Continuous monitoring of mortality, clinical signs, and behavioral abnormalities
- Body weight measurement before dosing, at least weekly, and at study termination
- Gross necropsy examination of all animals, with optional organ weighing and histopathology of target organs
- GHS-based acute toxicity classification and hazard categorization for labeling and safety data sheets
Testing Methods
Animal Selection and Preparation
Healthy adult SPF-grade rodents, commonly female Sprague-Dawley rats of approximately 180 to 220 grams and female ICR or Kunming mice of approximately 18 to 25 grams, are selected because females are generally slightly more sensitive in acute toxicity studies. Animals are randomized and acclimatized for at least three to seven days under controlled environmental conditions, including temperature of 20 to 26 degrees Celsius, relative humidity of 40 to 70 percent, and a 12-hour light/dark cycle, with nutritionally adequate rodent diet provided in accordance with GB 14924.
Dose Administration
The test substance is prepared in a suitable vehicle such as purified water, 0.5 percent carboxymethylcellulose sodium solution, or corn oil, and administered once by oral gavage using a blunt-tip feeding needle attached to a calibrated syringe. Rats are fasted overnight and mice for approximately three to four hours before dosing, with water provided ad libitum. The administration volume is kept constant across dose groups and typically does not exceed 10 mL per kilogram of body weight.
Acute Toxic Class Method (OECD TG 423)
This stepwise procedure uses fixed dose levels of 5, 50, 300, and 2000 mg/kg body weight, with three animals per step. Depending on the mortality observed, the study proceeds to a higher or lower dose level or is concluded, and the substance is assigned to one of the defined GHS acute toxicity categories. The method substantially reduces animal use while providing sufficient information for regulatory classification.
Up-and-Down Procedure (OECD TG 425)
This sequential design doses animals one at a time, typically starting at 175 mg/kg, with each subsequent dose increased or decreased by a factor of approximately 3.2 depending on the survival of the previous animal. Dosing stops when predefined stopping criteria are met, and the LD50 is estimated using maximum likelihood statistical analysis. The procedure is particularly efficient for substances with limited prior toxicity data.
Fixed Dose Procedure (OECD TG 420)
The Fixed Dose Procedure administers fixed dose levels of 5, 50, 300, and 2000 mg/kg body weight and classifies the substance according to the presence or absence of evident signs of toxicity at these levels, rather than relying on death as the endpoint. This approach reflects a strong commitment to animal welfare and humane endpoints.
Observation and Endpoint Assessment
All animals are observed clinically during the first several hours after dosing and at least once daily throughout the 14-day observation period. Recorded observations include demeanor, posture, gait, fur and skin condition, secretions, respiration, and central nervous system, autonomic, and somatomotor signs. Humane endpoints are applied whenever severe distress is observed. Body weights are recorded before dosing, weekly thereafter, and at termination, followed by gross necropsy of all animals, including those that died during the study.
Quality Assurance and Animal Welfare
Studies are performed in GLP-compliant accredited third-party laboratories following an approved study plan, with independent quality assurance audits of protocols, raw data, and final reports. All procedures are reviewed and approved by the institutional animal care and use committee, and the 3Rs principles are strictly applied through refined study designs, reduced animal numbers, and humane euthanasia practices where required.
Applications
The results of rat and mouse acute oral toxicity studies underpin a wide range of regulatory, commercial, and scientific decisions across industries.
- Notification and registration of new chemical substances under chemical inventory regimes in China and other major markets
- GHS-based classification and labeling of substances and mixtures, including preparation of safety data sheets
- Food safety toxicological evaluation of new food ingredients and additives under the GB 15193 series
- Pesticide and agrochemical registration dossiers and product label hazard statements
- Safety assessment support files for cosmetics ingredients and raw material suppliers
- Biological evaluation of medical devices within the ISO 10993 risk management framework
- Occupational health assessment and workplace hazard communication programs
- Classification for the transport of dangerous goods
By translating LD50 values and clinical observations into standardized hazard categories, these studies enable manufacturers, importers, and downstream users to communicate risks consistently, select appropriate protective measures, and demonstrate product compliance to regulators worldwide.
FAQ
What is the LD50 and why is it important?
The LD50, or median lethal dose, is the statistically estimated single oral dose that causes death in 50% of treated animals. It provides a quantitative measure of acute toxicity that allows substances to be ranked, classified under the GHS system, and managed with appropriate risk mitigation measures.
Why are both rats and mice commonly used?
Rats and mice are the standard rodent models for acute toxicity because their physiological responses to ingested substances are well characterized and their use is accepted by regulators worldwide. Testing in two rodent species helps account for interspecies variability and is required or recommended in many regulatory frameworks.
How many animals are required for a typical study?
Animal numbers depend on the chosen guideline. The Acute Toxic Class Method (OECD TG 423) typically uses six to twelve animals in total, the Up-and-Down Procedure (OECD TG 425) often requires fewer than ten animals, and the Fixed Dose Procedure (OECD TG 420) uses small fixed groups. Modern designs have dramatically reduced animal use compared with classical LD50 methods.
What is the typical duration of the study?
Including acclimatization, dosing, the 14-day observation period, necropsy, and report preparation, a standard acute oral toxicity study is usually completed within four to six weeks.
What dose levels are selected?
Dose selection is based on existing data, structure-activity relationships, and range-finding observations where necessary. The guideline-based methods use fixed dose levels of 5, 50, 300, and 2000 mg/kg body weight, with a limit test at 2000 or 5000 mg/kg applied when the substance is expected to be of low toxicity.
How is animal welfare protected during testing?
All studies are approved by an animal ethics committee and performed under the 3Rs principles. Animals are monitored at least daily, environmental enrichment is provided, humane endpoints are applied to prevent unnecessary suffering, and validated humane euthanasia methods are used at study termination.
What sample information should be submitted with a test request?
Sponsors typically provide 20 to 100 grams or milliliters of the test substance, depending on the dose range and study design, along with the certificate of analysis, purity, physicochemical properties, solubility information, safety data sheet, and any existing toxicity data to support dose selection.